STOCK TITAN
  1. Home
  2. News
  3. ABC

AMERISOURCEBERGEN CORP - ABC STOCK NEWS

Welcome to our dedicated page for AMERISOURCEBERGEN news (Ticker: abc), a resource for investors and traders seeking the latest updates and insights on AMERISOURCEBERGEN stock.

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, is a leading global pharmaceutical solutions organization dedicated to improving the lives of people and animals worldwide. With a unified identity and vision under the new name, Cencora connects pharmaceutical innovators, care providers, pharmacies, and patients to ensure the seamless and reliable delivery of vital therapies and healthcare products.

Headquartered in Conshohocken, Pennsylvania, Cencora boasts a comprehensive portfolio of services across the pharmaceutical value chain. The company is renowned for its robust pharmaceutical distribution network, specialty logistics, and biopharma services, ensuring medications reach their destinations efficiently and safely. Cencora's extensive reach is evidenced by its operations in over 50 countries, supported by a team of more than 46,000 dedicated employees.

Cencora's commitment to innovation is further highlighted through initiatives like Cencora Ventures, the company's corporate venture fund dedicated to fostering healthcare advancements. Additionally, the Cencora Impact Foundation underscores the company's dedication to social responsibility, with a recent $5 million donation to support global healthcare initiatives, including a significant grant to UNICEF Health Fund.

Financially, Cencora is a powerhouse with more than $200 billion in annual revenue, ranking #11 on the Fortune 500 and #24 on the Global Fortune 500. The company's strategic investments, such as the acquisition of OneOncology and PharmaLex, showcase its focus on expanding its specialty and global commercialization services. Cencora's recent name change reflects its bold vision and purpose-driven approach to creating healthier futures, unifying its global presence under one cohesive brand.

News

Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release

Rhea-AI Summary
Cencora, Inc. (NYSE: COR) plans to release Q4 2023 results on November 2, 2023, before the opening of trading on NYSE. Conference call to discuss results at 8:30 a.m. ET. Webcast available on investor.cencora.com. Replays available via telephone and webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News

AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care

Rhea-AI Summary
Cencora, Inc. completes name and stock ticker change, announces $5 million commitment to philanthropy
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors

Rhea-AI Summary
AmerisourceBergen Corporation (NYSE: ABC) announces election of Werner Baumann and Lauren M. Tyler as new independent directors, increasing the Board of Directors to twelve members, ten of whom are independent. Mr. Baumann, former Chairman and CEO of Bayer AG, and Ms. Tyler, currently Executive Vice President of J.P. Morgan Asset and Wealth Management, bring extensive experience in multinational companies and finance to oversee long-term sustainable growth at AmerisourceBergen.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.17%
Tags
management
News

Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds

Rhea-AI Summary
Walgreens Boots Alliance (WBA) Announces Sale of AmerisourceBergen (ABC) Shares and Concurrent Share Repurchase, Generating $1.6 Billion in Current Proceeds. The sale was executed through prepaid variable share forward transactions, providing liquidity while maintaining the ability to participate in potential stock price appreciation. The proceeds will be used for debt paydown and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase

Rhea-AI Summary
AmerisourceBergen Corporation (NYSE: ABC) has announced a registered public offering of 10.5 million shares of common stock in connection with Walgreens Boots Alliance Holdings LLC. The offering will be conducted through Goldman Sachs & Co. LLC. The Company will not receive any proceeds from the sale of shares, and the underwriter may offer the shares in various transactions. The offering is expected to close on or about August 8, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.15%
Tags
buyback offering
-
News

AmerisourceBergen Reports Fiscal 2023 Third Quarter Results

Rhea-AI Summary
AmerisourceBergen Corporation reports an 11.5% increase in revenue to $66.9 billion for the third quarter of fiscal year 2023. GAAP diluted EPS is $2.35, while adjusted diluted EPS is $2.92. The company raises its adjusted diluted EPS guidance range to $11.85 to $11.95 for fiscal 2023. AmerisourceBergen will change its name to Cencora and trade under the ticker symbol 'COR' starting August 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.23%
Tags
earnings
News

AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
earnings
-
News

TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News

AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
buyback
News

Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds

Rhea-AI Summary
Walgreens Boots Alliance has sold shares of AmerisourceBergen Corporation for $644 million through variable prepaid forward transactions. They have also entered into a share repurchase agreement with AmerisourceBergen for $50 million. The proceeds will be used for debt paydown and general corporate purposes. The sale has no impact on the long-term partnership between the two companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the market cap of AMERISOURCEBERGEN (abc)?

The market cap of AMERISOURCEBERGEN (abc) is approximately 36.1B.

What is Cencora, Inc.?

Cencora, Inc., formerly AmerisourceBergen Corporation, is a global pharmaceutical solutions organization focused on improving the lives of people and animals through secure, reliable delivery of healthcare products and services.

Why did AmerisourceBergen change its name to Cencora?

The name change to Cencora reflects the company's unified global presence and its commitment to creating healthier futures with a purpose-driven approach. It represents the company's vision and strategic growth in the healthcare sector.

What services does Cencora provide?

Cencora offers a wide range of services, including pharmaceutical distribution, specialty logistics, biopharma services, and market access solutions, ensuring that medications and healthcare products reach their destinations efficiently and safely.

What recent strategic investments has Cencora made?

Cencora has recently acquired OneOncology, a network of leading oncology practices, and PharmaLex, a regulatory consulting firm. These investments enhance Cencora's specialty services and global commercialization capabilities.

How does Cencora contribute to social responsibility?

Cencora is committed to social responsibility through initiatives like the Cencora Impact Foundation, which recently announced a $5 million donation to support global healthcare efforts, including a significant grant to the UNICEF Health Fund.

What is Cencora Ventures?

Cencora Ventures, formerly known as AB Health Ventures, is Cencora's corporate venture fund dedicated to advancing healthcare innovation. The fund supports startups and initiatives that align with Cencora's mission to improve healthcare access globally.

How large is Cencora's workforce?

Cencora employs over 46,000 team members worldwide, working across various segments of the pharmaceutical value chain to ensure the delivery of critical healthcare products and services.

What is Cencora's financial standing?

Cencora is a financial leader in the healthcare industry, with more than $200 billion in annual revenue. The company is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500.

When did Cencora begin trading under the new ticker symbol?

Cencora began trading under the new ticker symbol 'COR' on the New York Stock Exchange on August 30, 2023.

What is the purpose of the Cencora Healthier Futures Grant Program?

The Cencora Healthier Futures Grant Program, launched by the Cencora Impact Foundation, aims to support healthcare innovation and access for underserved populations. The inaugural grant of $500,000 was awarded to the UNICEF Health Fund.
Stock ABC logo
AMERISOURCEBERGEN CORP

NYSE:ABC

ABC Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

ABC Stock Data

36.15B
215.85M
16.68%
78.92%
3.5%
Medical Distribution
Healthcare
Link
United States
Conshohocken